Endometrial histology and bleeding patterns in post-menopausal women taking sequential, combined estradiol and dydrogesterone

Maturitas

Volumn 26, Issue 3, 1997, Pages 219-226

  Ferenczy, Alex ^a   Gelfand, Morrie M ^b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

amenorrhea; dydrogesterone; estradiol; hormone replacement therapy; post menopausal

Indexed keywords

DYDROGESTERONE; ESTRADIOL;

ADULT; AMENORRHEA; ARTICLE; BLEEDING; CANADA; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; ENDOMETRIUM; FEMALE; HISTOLOGY; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE;

CLIMACTERIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; DYDROGESTERONE; ENDOMETRIUM; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MENSTRUAL CYCLE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 0030915191     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(97)01104-3     Document Type: Article

References (18)

1. Grady D, Rubin SM, Petitti DB et al. Hormone therapy to prevent disease and prolong life in post-menopausal women. Ann Intern Med 1992; 1117: 1016-1037.
2. Grady D, Gebretsadlk T, Kerlikowske K, Ernster V, Petitti D. Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol 1995; 85: 304-313.
3. Ferenczy A. Anatomy and histology of the uterine corpus. In: Kurman RJ, ed. Blaustein's Pathology of the Female Genital Tract. New York: Springer-Verlag, 1994; 327-366.
4. Cust MP, Gangar KF, Hillard TC, Whitehead MI. A risk benefit assessment of estrogen therapy in post-menopausal women. Drug Safety 1990; 5: 345-358.
5. Henderson BE. The cancer question: an overview of recent epidemiologic and retrospective data. Am J Obstet Gynecol 1989; 161: 1859-1864.
6. Harlap S, The benefits and risk of hormone replacement therapy: an epidemiologic overview. Am J Obstet Gynecol 1992; 166: 1986-1992.
7. Jager FC, Michielsen PMLJ, Minter B et al. Summary of the properties of dydrogesterone. Duphar Report 1987 (Int. Doc. No. 56681/265/1987).
8. Lievertz RW. Pharmacology and pharmacokinetics of estrogens. Am J Obstet Gynecol 1987; 156: 1289-1293.
9. Archer DF, Pickar JH, Bottiglioni F. Bleeding patterns in post-menopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Obstet Gynecol 1994; 83: 686-692.
10. Moyer DL, de Lignieres B, Driguez P, Fez JP. Prevention of endometrial hyperplasia by progesterone during long-term estradiol replacement: influence of bleeding pattern and secretory changes. Fertil Steril 1993; 59: 992-997.
11. van der Mooren MJ, Hanselaar AG, Born GF, Rolland R. Changes in the withdrawal bleeding pattern and endometrial histology during 17-β estradiol-dydrogesterone therapy in post-menopausal women: a 2-year prospective study. Maturitas 1994; 20: 175-180.
12. Woodruff JD, Pickar JH for the Menopause Study Group. Incidence of endometrial hyperplasia in post-menopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. Am J Obstet Gynecol 1994; 170: 1213-1223.
13. The Post-menopausal Estrogen/Progestin Interventions (PEPI) Trial. Effects of hormone replacement therapy on endometrial histology in post-menopausal women. J Am Med Assoc 1996; 275: 370-375.
14. Burch DJ, Spowart KJM, Jesinger DK et al. A dose-ranging study of the use of cyclical dydrogesterone with continuous 17-β estradiol. Br J Obstet Gynaecol 1995; 102; 243-248.
15. Luciano AA, Nuran Turksoy R, Carleo J, Hendrix JW. Clinical and metabolic responses of menopausal women to sequential versus continuous estrogen and progestin replacement therapy. Obstet Gynecol 1988; 71: 39-43.
16. Gambrell RD Jr. Use of progestin therapy. Am J Obstet Gynecol 1987; 156: 1304-1313.
17. Bewtra C, Kable WT, Gallagher JC. Endometrial histology and bleeding patterns in menopausal women treated with estrogen and continuous or cyclic progestin. J Reprod Med 1988; 33: 205-208.
18. Archer DF, Fischer LA, Rich D et al. Estrace R vs Premarin R for treatment of menopausal symptoms: dosage comparison study. Adv Ther 1992; 9: 21-31.